Nuclear stocks remain one of the clearest power-scarcity trades in the market. The investment case is increasingly tied to hard demand from artificial-intelligence data centers, grid-reliability requirements and energy-security policy rather than decarbonization alone. Nuclear plants offer dependable baseload generation, while the broader supply chain stands to benefit if utilities and large power users commit to long-duration procurement. Equinix’s August 14, 2025 announcement of multiple advanced-nuclear electricity deals, including power purchase agreements and microreactor pre-orders, showed how hyperscalers are beginning to treat nuclear as a practical answer to load growth.
The structural bull case also rests on a widening gap between uranium demand and slow-moving capacity across mining, conversion, enrichment and reactor construction. That backdrop has supported long-term contracting and kept attention on uranium pricing. Investors can choose among uranium miners, fuel-cycle companies, reactor developers, utilities and nuclear infrastructure suppliers. These groups do not behave alike: miners are sensitive to commodity prices, fuel-cycle businesses to contracting and enrichment capacity, and advanced-reactor developers to regulation, financing and project execution.
This list presents seven nuclear-related stocks in countdown order, from #7 down to #1. The ranking emphasizes depth of exposure to the nuclear theme first and business fundamentals second, so the list includes both established companies with current operations and higher-beta technology or development stories. The result is a spectrum of ways to participate in potential nuclear buildout, from uranium resources and fuel services to components and next-generation reactor platforms.
Our screen was limited to US-listed companies with market capitalizations above $500 million and meaningful exposure to nuclear mining, fuel, components, power generation or reactor technology. We ranked qualifying names by the depth of that exposure, then used profitability, growth, valuation, earnings consistency and balance-sheet signals to separate companies with stronger underlying businesses from speculative positions. The data line in each section uses evergreen figures rather than a daily quote. This is a countdown: the best pick is disclosed at #1.
What they do. The company explores, develops and processes uranium and titanium concentrate properties in the United States, Canada and Paraguay. Its model is centered on advancing resource assets through pre-extraction, extraction and processing, giving investors direct mineral-development exposure rather than the regulated cash flows of a nuclear utility. The multijurisdiction asset base is the main source of strategic optionality.
Why it fits.UEC is a direct uranium-supply play, making it highly exposed to the fuel-demand and scarcity dynamics behind the nuclear theme. Its focus on US, Canadian and Paraguayan properties also gives the stock relevance to energy-security discussions, although the investment case remains tied to successful project development and uranium-market conditions. This is a more concentrated commodity and execution bet than an established nuclear equipment supplier.
Numbers that matter. The financial profile is currently weak: revenue was $20.2 million, down 59.4% year over year, while earnings declined 80.6% year over year. TTM EPS was negative $0.23, with next-year EPS estimated at negative $0.09, and the company reported a negative 396.0% gross margin and negative $120.762 million of EBITDA. The forward P/E of 178.5714 is difficult to interpret alongside ongoing losses, which helps explain the composite grade of C and Sell recommendation.
Recent momentum.UEC’s completed earnings history shows zero beats in seven reported quarters. In the latest completed quarter listed, dated June 9, 2026, EPS was negative $0.07 versus a negative $0.01 estimate, producing a negative 600.0% surprise. Analysts list five Buy ratings, with no Hold or Sell ratings shown, and an average target of $18.0278, but that bullish consensus sits against a still-unprofitable operating record.
What they do. Ur-Energy acquires, explores, develops and operates uranium mineral properties in the United States. It holds interests in 12 US projects, including the Lost Creek project in Wyoming, which covers approximately 1,800 unpatented mining claims and three mineral leases totaling about 35,400 acres. The revenue model depends on moving those properties through development and operation, so the company offers a focused but early-stage uranium-production profile.
Why it fits.URG’s direct exposure to US uranium properties places it squarely in the fuel-scarcity portion of the nuclear market. Lost Creek and the broader project portfolio provide a specific asset base for potential supply growth as utilities seek dependable fuel, while the US focus aligns with energy-security priorities. The trade-off is greater sensitivity to mine execution, uranium prices and financing than investors face with diversified nuclear infrastructure businesses.
Numbers that matter. Revenue grew 37.7% year over year to $35.076 million, but profitability remains deeply negative. TTM EPS was negative $0.24, while next-year EPS is estimated at $0.0043; gross margin was negative 164.3%, operating margin negative 128.27% and net margin negative 252.34%. EBITDA was negative $67.222 million, and the forward P/E of 156.25 leaves little valuation support if the expected move toward profitability is delayed.
Recent momentum.URG has not beaten estimates in any of the eight quarters in the supplied earnings history. On August 10, 2026, it reported EPS of negative $0.04 versus a negative $0.03 estimate, a negative 33.3% surprise. The analyst panel contains two Buy ratings and no Hold or Sell ratings shown, with an average target of $2.1611, while the composite grade is D+ and the overall composite recommendation is Strong Sell.
What they do.BWXT manufactures nuclear components, reactors and fuel across Government Operations and Commercial Operations. Its portfolio includes naval nuclear components, commercial steam generators, pressure vessels, fuel-handling systems, reactor components, nuclear-waste containers, research-reactor fuel and medical radioisotopes. Revenue comes from specialized manufacturing, engineering, inspection, maintenance and nuclear plant lifecycle services, while proprietary and sole-source valves, manifolds and fittings support its competitive position in selected customer programs.
Why it fits.BWXT provides broad nuclear-infrastructure exposure without relying on uranium prices alone. Its government work connects the company to naval reactors and nuclear fuel, while its commercial business reaches equipment, fuel handling and plant lifecycle support. That mix makes BWXT a comparatively established way to participate in nuclear demand, including the long-term need to maintain existing reactors and build specialized components for future systems.
Numbers that matter. The fundamentals distinguish BWXT from the loss-making developers and miners lower in the countdown. Revenue grew 18.0% year over year to approximately $3.514 billion, earnings grew 14.1% and TTM EPS was $3.80, with next-year EPS estimated at $5.2541. Gross margin was 22.1%, operating margin 10.39%, net margin 10.11% and EBITDA $476.492 million. The valuation is substantial at a trailing P/E of 42.7 and forward P/E of 38.3142, but it is supported by positive earnings and a 28.29% ROE.
Recent momentum.BWXT has beaten EPS estimates in all eight quarters in the supplied history. Its August 3, 2026 result was $1.07 per share versus an estimate of $1.01, a 5.9% beat, following a 20.4% beat in May. Analysts show two Buy ratings and four Hold ratings, with no Sell ratings listed, and an average target of $234.4479. The composite grade is B with a Neutral overall recommendation, reflecting strong execution alongside demanding valuation and debt-equity concerns.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
What they do. Energy Fuels explores, recovers, recycles, develops and sells materials associated with uranium properties in the United States. It operates through Uranium, rare earth elements and heavy mineral sands segments, producing and selling vanadium pentoxide, rare earth elements, carbonate, ilmenite, rutile, zircon and monazite. That multi-segment model gives the company a wider materials footprint than a pure uranium miner, though its financial profile remains tied to the economics of developing and processing these resources.
Why it fits.UUUU has direct uranium exposure and adds fuel-adjacent rare-earth and heavy-mineral operations. Its recovery and recycling activities connect the company to the broader nuclear-materials supply chain, while the Uranium segment gives it sensitivity to the same supply scarcity that supports the nuclear theme. The diversification can broaden the opportunity set, but it also makes the stock less of a clean uranium-price proxy.
Numbers that matter. Revenue growth was an exceptional 496.1% year over year, but earnings growth was negative 97.2%, showing how sharply the top-line increase has failed to translate into profits. TTM EPS was negative $0.33, while next-year EPS is estimated at $0.485. Gross margin was 40.9%, but operating margin was negative 79.03%, net margin negative 77.3% and EBITDA negative $71.665 million. The forward P/E of 212.766 prices in substantial improvement despite the current losses.
Recent momentum. Energy Fuels has recorded zero EPS beats in the eight quarters provided. In the latest quarter, dated August 5, 2026, EPS was negative $0.13 versus a negative $0.05 estimate, a negative 160.0% surprise. Analysts list one Buy and one Hold rating, with no Sell rating shown, and an average target of $24.10. The composite grade is D+ with a Strong Sell recommendation, underscoring the gap between the stock’s nuclear-materials exposure and its current earnings execution.
What they do. Centrus supplies nuclear fuel components to utilities operating nuclear power plants in the United States, Japan, the Netherlands and other international markets. Its Low-Enriched Uranium segment sells separative work units, natural uranium hexafluoride, uranium concentrates, conversion and enriched uranium products, while Technical Solutions provides manufacturing, engineering and operations services. This combination gives Centrus a specialized position in the fuel cycle rather than direct exposure to electricity generation.
Why it fits. Centrus is one of the most direct ways in this group to access the conversion, enrichment and fuel-component bottlenecks highlighted by the nuclear thesis. Its customer base includes nuclear utilities, and its Technical Solutions segment adds industrial and engineering capabilities around the fuel cycle. Because nuclear reactors require continuing fuel services, the company is exposed to longer-duration demand than an exploration-stage resource developer, although earnings can still be uneven.
Numbers that matter. Revenue grew 14.0% year over year to $473.9 million, and TTM EPS was positive at $1.98. However, earnings growth was negative 51.6%, while next-year EPS is estimated at $3.746, reflecting a recovery-oriented outlook rather than a smooth growth profile. Gross margin was 23.7%, operating margin 5.34%, net margin 10.23% and EBITDA $10.1 million. Valuation remains demanding at a trailing P/E of 92.7677 and forward P/E of 86.2069.
Recent momentum. Centrus has beaten estimates in five of the eight supplied quarters. On August 5, 2026, it reported EPS of $0.77 against an estimate of $0.74, a 4.1% beat; the prior quarter produced a 288.9% surprise. Analysts show one Buy and two Hold ratings, with no Sell rating listed, and an average target of $257.3333. The C+ composite grade and Sell recommendation temper that constructive analyst view, particularly given the high earnings multiple and volatile quarterly history.
Pick #2Premium members only
Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
The screen covered US-listed companies with market capitalizations above $500 million and identifiable exposure to uranium, enrichment, nuclear components, reactor technology or nuclear power. We ranked the seven qualifying stocks first by the depth and directness of their nuclear exposure, then by business fundamentals including revenue and earnings growth, margins, returns, valuation, balance-sheet signals and earnings consistency. Primary-source financial data, analyst estimates and our composite quality metrics informed the underwriting. The article is refreshed monthly, so the countdown and evergreen data lines should be reassessed as valuations, operating results and analyst expectations change.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
